ECM1
ECM1 (extracellular matrix protein 1) is a soluble, secreted protein found in the extracellular matrix. It acts in endochondral bone formation, angiogenesis and skin homeostasis, and it is the gene linked to lipoid proteinosis. Browse Assay Genie's current range of ECM1 research reagents below, or read on for the biology behind the target.
ECM1 is a secreted protein that localises to the extracellular space and extracellular matrix. It is involved in endochondral bone formation, where it acts as a negative regulator of bone mineralization. It also stimulates the proliferation of endothelial cells and promotes angiogenesis, and it inhibits the proteolytic activity of MMP9.
The ECM1 gene encodes a soluble protein that, according to the NCBI Gene summary, is involved in endochondral bone formation, angiogenesis and tumour biology. The protein interacts with a variety of extracellular and structural proteins, and this contributes to the maintenance of skin integrity and homeostasis. Alternatively spliced transcript variants encoding distinct isoforms have been described. The mouse and rat orthologues are both named Ecm1.
Mutations in the ECM1 gene are associated with lipoid proteinosis, also known as hyalinosis cutis et mucosae or Urbach-Wiethe disease. The disorder is characterised by generalised thickening of the skin, mucosae and certain viscera. Because ECM1 connects matrix biology, vascular growth and protease control, it is studied in skeletal development, skin disease and cancer research.
ECM1 is involved in endochondral bone formation and negatively regulates bone mineralization, making it relevant to studies of skeletal development.
ECM1 stimulates endothelial cell proliferation and promotes angiogenesis, so it is studied in vascular growth and remodelling.
ECM1 supports skin integrity and homeostasis, and its mutations are associated with lipoid proteinosis (Urbach-Wiethe disease).
ECM1 has been implicated in tumour biology and inhibits MMP9 proteolytic activity, linking it to matrix turnover studies.
ECM1 is a secreted extracellular matrix protein. It negatively regulates bone mineralization during endochondral bone formation, stimulates endothelial cell proliferation, promotes angiogenesis and inhibits MMP9 proteolytic activity. It also interacts with extracellular and structural proteins and helps maintain skin integrity and homeostasis.
The approved HGNC name is extracellular matrix protein 1, and no alternative symbols or previous names are listed. NCBI Gene notes that alternatively spliced transcript variants encoding distinct isoforms have been described, so check the datasheet of any product for the isoforms it recognises.
Yes. Mutations in the ECM1 gene are associated with lipoid proteinosis (Urbach-Wiethe disease), which causes thickening of skin, mucosae and certain viscera. Orthologues named Ecm1 exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Matrix proteases and other extracellular matrix, angiogenesis and bone biology targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16610; product specifications from Assay Genie datasheets.